Tampa General Hospital (TGH) has appointed internationally recognized medical oncologist and clinical researcher Dr. Marshall Posner as associate director of Clinical Investigations at the TGH Cancer Institute.
Dr. Posner is a world-class leader in the field of medical oncology, a gifted physician and a highly accomplished clinical researcher with over 280 peer-reviewed publications. He graduated from Yale University, New Haven, Connecticut and Tufts University School of Medicine, Boston. He completed his residency in internal medicine at Boston City Hospital and a fellowship in medical oncology at the Dana-Farber Cancer Institute, Boston where he earned the position of medical director of the head and neck oncology program, and associate professor at Harvard Medical School, Boston.
In 2010, Dr. Posner was recruited to the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai in New York City as professor of Medicine, medical director, Head and Neck Cancer Program, and associate director, Cancer Clinical Trials Office. During his tenure at the Mount Sinai Health System, he also served as associate director of the Center for Personalized Cancer Therapeutics, associate director for Research Infrastructure and co-leader of the Cancer Clinical Investigation Program, National Cancer Institute Cancer Center Support Grant (P30 Grant) and co-chair, of the Protocol Review and Monitoring Committee (PRMC).
